M

Medicofarma Biotech SA
WSE:MDB

Watchlist Manager
Medicofarma Biotech SA
WSE:MDB
Watchlist
Price: 0.377 PLN -2.08% Market Closed
Market Cap: 25.6m PLN
Have any thoughts about
Medicofarma Biotech SA?
Write Note

Medicofarma Biotech SA
PP&E Net

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Medicofarma Biotech SA
PP&E Net Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company PP&E Net CAGR 3Y CAGR 5Y CAGR 10Y
M
Medicofarma Biotech SA
WSE:MDB
PP&E Net
zł12.6m
CAGR 3-Years
N/A
CAGR 5-Years
191%
CAGR 10-Years
N/A
I
Inno-Gene SA
WSE:IGN
PP&E Net
zł660k
CAGR 3-Years
-5%
CAGR 5-Years
-10%
CAGR 10-Years
-14%
R
Ryvu Therapeutics SA
WSE:RVU
PP&E Net
zł74.2m
CAGR 3-Years
-7%
CAGR 5-Years
5%
CAGR 10-Years
28%
S
Selvita SA
WSE:SLV
PP&E Net
zł328.6m
CAGR 3-Years
43%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Medicofarma Biotech SA
Glance View

Market Cap
25.6m PLN
Industry
Life Sciences Tools & Services

Medicofarma Biotech SA is a biotechnology company, which focuses on the innovative medicine, medicinal products, and biotechnology products. The company is headquartered in Warsaw, Woj. Mazowieckie. The company went IPO on 2008-11-27. The company is engaged in works on drugs, medical devices and biotechnological products. It's research and development works are carried out in laboratories in Lublin and Poznan.

MDB Intrinsic Value
0.096 PLN
Overvaluation 75%
Intrinsic Value
Price
M

See Also

What is Medicofarma Biotech SA's PP&E Net?
PP&E Net
12.6m PLN

Based on the financial report for Dec 31, 2023, Medicofarma Biotech SA's PP&E Net amounts to 12.6m PLN.

What is Medicofarma Biotech SA's PP&E Net growth rate?
PP&E Net CAGR 5Y
191%

Over the last year, the PP&E Net growth was 0%.

Back to Top